Latest News and Press Releases
Want to stay updated on the latest news?
-
Management to be Joined by Two Clinical Leaders in the Breast Cancer Field Expected to Complete Enrollment in Ongoing ELAINE-3 Phase 3 Registrational Study of Lasofoxifene in Metastatic Breast...
-
PridCor secures global antiviral portfolio with Phase 2b and Phase 3 assets to advance treatments for Long COVID and chronic illness.
-
MALVERN, Pa., April 23, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that...
-
Austin, TX, USA, April 23, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Automated Insulin Delivery System Market Size, Trends and Insights By Product...
-
Exicure enters co-development agreement with Adbiotech to advance Burixafor (GPC-100) combination therapies across multiple indications.
-
Kneat will release its financial results for the quarter ended March 31, 2026, after TSX market close on May 13, 2026.
-
GREENVILLE, S.C., 22 avr. 2026 (GLOBE NEWSWIRE) -- MECART a annoncé aujourd’hui les résultats d’une analyse du cycle de vie (ACV), démontrant que ses systèmes de salles blanches présentent des...
-
Peer‑reviewed life cycle assessment shows MECART cleanroom systems have lower environmental impacts than the average North American cleanroom.
-
Bolstered leadership team positions Paratus to accelerate PS-1001 toward the clinic and build a pipeline of differentiated medicines.
-
Charlottesville, Virginia, April 22, 2026 (GLOBE NEWSWIRE) -- Luminoah, a medical technology company focused on modernizing enteral nutrition, today announced it has received U.S. Food and Drug...